293736-67-1

293736-67-1 structure
293736-67-1 structure
  • Name: RTA 744
  • Chemical Name: (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-6-methyl-5-phenylmethoxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione,hydrochloride
  • CAS Number: 293736-67-1
  • Molecular Formula: C34H36ClNO11
  • Molecular Weight: 670.10300
  • Catalog: Signaling Pathways Apoptosis Apoptosis
  • Create Date: 2017-10-21 01:48:29
  • Modify Date: 2025-08-26 14:44:51
  • RTA 744 (WP 744) is a Doxorubicin (HY-15142A) analogue. RTA 744 triggers apoptosis and cell killing in NB cells by activating proapoptotic mediators. RTA 744 has proapoptotic and anti-leukemia activities. RTA 744 can be used for cancer research[1][2][3].

Name (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-6-methyl-5-phenylmethoxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione,hydrochloride
Synonyms Berubicin HCl
WP744
RTA-744
Berubicin hydrochloride (USAN)
Description RTA 744 (WP 744) is a Doxorubicin (HY-15142A) analogue. RTA 744 triggers apoptosis and cell killing in NB cells by activating proapoptotic mediators. RTA 744 has proapoptotic and anti-leukemia activities. RTA 744 can be used for cancer research[1][2][3].
Related Catalog
In Vitro WP 769 hydrochloride 抑制 K562 细胞的活性,IC50 值为 0.18 mg/mL[1]。 WP 769 hydrochloride (0-100 µM;24 h) 抑制 KBM-5 细胞吸收胸腺嘧啶[2]。 WP 769 hydrochloride (1 µM;15 min) 在 KBM-5 细胞中通过 NF-κB 的 p50 和 p65 亚基激活 NF-κB[2]。 WP 769 hydrochloride (0-100 µM;72 h) 以剂量依赖性方式抑制 Jurkat 和 RIP 缺失的 Jurkat 细胞增值[2]。 Cell Viability Assay[2] Cell Line: KBM-5 cells. Concentration: 0, 0.1, 1, 10 and 100 µM. Incubation Time: 24 h. Result: Inhibited cell viability with dose-dependent manner. Western Blot Analysis[2] Cell Line: KBM-5 cells. Concentration: 0, 0.1, 1 and 10 µM. Incubation Time: 4 h. Result: Increased NF-κB expression with time and dose dependent manner. Cell Viability Assay[3] Cell Line: SH-SY5Y cells. Concentration: 0.1, 1 and 10 µM. Incubation Time: 0, 1, 2, 3, 4 and 5 d. Result: Inhibited cell viability with dose-dependent manner. Apoptosis Analysis[3] Cell Line: SH-SY5Y cells. Concentration: 50, 500 and 2000 nM. Incubation Time: 48 h. Result: Promoted cell apoptosis. Western Blot Analysis[3] Cell Line: SH-SY5Y cells. Concentration: 0, 0.1, 1.0 or 10 µM. Incubation Time: 0, 0.5, 1, 2, 4, 6, 8, 12 or 24 h. Result: Activated Casp 3 and Casp 9. Increased p53 and NF-κB expression. Reduced IκBα expression.
References

[1]. Faderl S, et al. WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity. Anticancer Res. 2001 Nov-Dec;21(6A):3777-84.  

[2]. Ashikawa K, et al. Evidence that activation of nuclear factor-kappaB is essential for the cytotoxic effects of doxorubicin and its analogues. Biochem Pharmacol. 2004 Jan 15;67(2):353-64.  

[3]. Wu J, Harris NL, Inge TH. Nuclear factor-kappa B and apoptosis inducing factor activation by doxorubicin analog WP744 in SH-SY5Y neuroblastoma cells. J Surg Res. 2004 Dec;122(2):231-9.  

Molecular Formula C34H36ClNO11
Molecular Weight 670.10300
Exact Mass 669.19800
PSA 195.07000
LogP 3.72810
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.